| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $334.6M | +19.4% |
| SG&A Expense | $112.6M | +28.6% |
| Operating Income | -$447.3M | -21.6% |
| Interest Expense | $10.6M | +169.7% |
| Pre-tax Income | -$432.3M | -23.1% |
| Income Tax | $503K | +214.4% |
| Net Income | -$432.8M | -23.1% |
| EPS (Basic) | -$2.67 | -15.1% |
| EPS (Diluted) | -$2.67 | -15.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $416.5M | +205.1% |
| Current Assets | $1.01B | +11.2% |
| Total Assets | $1.24B | +22.2% |
| Current Liabilities | $92.2M | +27.0% |
| Long-term Debt | $379.5M | -2.2% |
| Total Liabilities | $569.6M | +14.7% |
| Stockholders' Equity | $673.7M | +29.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$342.3M | -16.8% |
| Capital Expenditures | $3.8M | -3.7% |
| Investing Cash Flow | $73.7M | +119.0% |
| Financing Cash Flow | $548.6M | -12.0% |
| Free Cash Flow | -$346.1M | -16.5% |